| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 97.12B | 95.06B | 85.50B | 59.29B | 93.36B | 98.20B |
| Gross Profit | 15.38B | 14.87B | 14.24B | 9.95B | 15.40B | 19.59B |
| EBITDA | 8.80B | 8.71B | 8.48B | 3.38B | 6.64B | 10.94B |
| Net Income | 5.99B | 5.86B | 5.32B | 1.67B | 4.32B | 6.85B |
Balance Sheet | ||||||
| Total Assets | 140.25B | 129.78B | 121.79B | 105.48B | 107.02B | 111.01B |
| Cash, Cash Equivalents and Short-Term Investments | 37.71B | 40.53B | 48.19B | 43.04B | 32.37B | 35.87B |
| Total Debt | 6.66B | 5.71B | 5.05B | 3.89B | 3.51B | 1.74B |
| Total Liabilities | 88.97B | 80.62B | 73.82B | 62.51B | 64.25B | 75.33B |
| Stockholders Equity | 43.22B | 41.16B | 40.27B | 35.91B | 35.67B | 32.12B |
Cash Flow | ||||||
| Free Cash Flow | 3.34B | 7.84B | 8.81B | 9.46B | -5.73B | 18.45B |
| Operating Cash Flow | 4.75B | 10.09B | 11.37B | 10.90B | -3.21B | 19.49B |
| Investing Cash Flow | -4.13B | -8.66B | -11.06B | -18.61B | -36.68M | -5.90B |
| Financing Cash Flow | -4.35B | -4.78B | -470.96M | -1.85B | 1.96B | -3.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$120.21B | 9.92 | 14.20% | 4.77% | 4.23% | -3.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | HK$125.04B | 4.18 | 7.18% | 6.36% | -0.11% | -10.59% | |
55 Neutral | HK$104.14B | 4.09 | 5.70% | 5.92% | -5.10% | 0.34% |